Citigroup »

Terns Pharmaceuticals shares owned by Citigroup

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Citigroup

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.0M 158k 6.50
2023-12-31 $43k 7.1k 6.00
2023-09-30 $4.2k 837 5.00
2023-03-31 $538k 45k 11.84
2022-12-31 $469k 46k 10.18
2022-09-30 $4.0k 701 5.71
2021-12-31 $30k 4.3k 7.00
2021-03-31 $13k 578 22.49